MRI Assessment of Ablation-Induced Scarring in Atrial Fibrillation: Analysis from the DECAAF Study. Akoum N, Wilber D, Hindricks G, Jais P, Cates J, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Hutchinson M, Herweg B, Daoud E, Wissn J Cardiovasc Electrophysiol 2015; 26(5): 473-480 ISSN 1045-3873 Impact factor: 3.156
The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy. Aronsson M, Walfridsson H, Janzon M, Walfridsson U, Nielsen JC, Hansen PS, Johannessen A, Raatikainen P, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Levin LA Europace 2015; 17(1): 48-55 ISSN 1099-5129 Impact factor: 3.670
First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Bohm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G Hypertension 2015; 65(4): 766-774 ISSN 0194-911X Impact factor: n.n.e.
EHRA research network surveys: 6 years of EP wires activity. Bongiorni MG, Chen J, Dagres N, Estner H, Hernandez-Madrid A, Hocini M, Larsen TB, Pison L, Potpara T, Proclemer A, Sciaraffia E, Todd D, Blomstrom-Lundqvist C Europace 2015; 17(11): 1733-1738 ISSN 1099-5129 Impact factor: n.n.e.
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Boriani G, Savelieva I, Dan GA, Deharo JC, Ferro C, Israel CW, Lane DA, La Manna G, Morton J, Mitjans AM, Vos MA, Turakhia MP, Lip GY Europace 2015; 17(8): 1169-1196 ISSN 1099-5129 Impact factor: 3.670
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM N Engl J Med 2015; 372(25): 2387-2397 ISSN 0028-4793 Impact factor: 55.873
Catheter ablation for atrial fibrillation: results from the first European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA) Part II. Chen J, Dagres N, Hocini M, Fauchier L, Bongiorni MG, Defaye P, Hernandez-Madrid A, Estner H, Sciaraffia E, Blomstrom-Lundqvist C Europace 2015; 17(11): 1727-1732 ISSN 1099-5129 Impact factor: n.n.e.
Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial. Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P EuroIntervention 2015; 11(5): 549-554 ISSN 1774-024X Impact factor: n.n.e.
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial. Dangas GD, Lefevre T, Kupatt C, Tchetche D, Schafer U, Dumonteil N, Webb JG, Colombo A, Windecker S, Ten Berg JM, Hildick-Smith D, Mehran R, Boekstegers P, Linke A, Tron C, Van Belle E, Asgar AW, Fach J Am Coll Cardiol 2015; 66(25): 2860-2868 ISSN 0735-1097 Impact factor: n.n.e.
Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging. de Waha S, Eitel I, Desch S, Fürnau G, Lurz P, Urban D, Schuler G, Thiele H Clin Res Cardiol 2015; 104(9): 727-734 ISSN 1861-0684 Impact factor: n.n.e.
European cardiac resynchronization therapy survey II: rationale and design. Dickstein K, Normand C, Anker SD, Auricchio A, Blomstrom CL, Bogale N, Cleland J, Filippatos G, Gasparini M, Gitt A, Hindricks G, Kuck KH, Ponikowski P, Stellbrink C, Ruschitzka F, Linde C Europace 2015; 17(1): 137-141 ISSN 1099-5129 Impact factor: 3.670
Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFRCT: outcome and resource impacts study. Douglas PS, Pontone G, Hlatky MA, Patel MR, Norgaard BL, Byrne RA, Curzen N, Purcell I, Gutberlet M, Rioufol G, Hink U, Schuchlenz HW, Feuchtner G, Gilard M, Andreini D, Jensen JM, Hadamitzky M, Chisw Eur Heart J 2015; 36(47): 3359-3367 ISSN 0195-668X Impact factor: n.n.e.
Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFRCT: outcome and resource impacts study. Douglas PS, Pontone G, Hlatky MA, Patel MR, Norgaard BL, Byrne RA, Curzen N, Purcell I, Gutberlet M, Rioufol G, Hink U, Schuchlenz HW, Feuchtner G, Gilard M, Andreini D, Jensen JM, Hadamitzky M, Chisw Eur Heart J 2015; 36(47): 3359-3367 ISSN 0195-668X Impact factor: n.n.e.
Effects of the olive tree leaf constituents on myocardial oxidative damage and atherosclerosis. Efentakis P, Iliodromitis EK, Mikros E, Papachristodoulou A, Dagres N, Skaltsounis AL, Andreadou I Planta Med 2015; 81(8): 648-654 ISSN 0032-0943 Impact factor: n.n.e.
Use of fluoroscopy in clinical electrophysiology in Europe: results of the European Heart Rhythm Association Survey. Estner HL, Grazia Bongiorni M, Chen J, Dagres N, Hernandez-Madrid A, Blomstrom-Lundqvist C Europace 2015; 17(7): 1149-1152 ISSN 1099-5129 Impact factor: n.n.e.
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Gorenek B, Blomstrom Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck KH, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz RR, Valgimigli M, Vos MA, Vrints C, Zeym EuroIntervention 2015; 10(9): 1095-1108 ISSN 1774-024X Impact factor: 3.769
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Gorenek B, Lundqvist CB, Terradellas JB, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck KH, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz RR, Valgimigli M, Vos MA, Vrints C, Zeymer U Eur Heart J Acute Cardiovasc Care 2015; 4(4): 386-389 ISSN 2048-8726 Impact factor: 0.000
Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation: is it necessary? Ha AC, Hindricks G, Birnie DH, Verma A Curr Opin Cardiol 2015; 30(1): 1-7 ISSN 0268-4705 Impact factor: 2.696
EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring. Heidbuchel H, Hindricks G, Broadhurst P, Van Erven L, Fernandez-Lozano I, Rivero-Ayerza M, Malinowski K, Marek A, Romero Garrido RF, Loscher S, Beeton I, Garcia E, Cross S, Vijgen J, Koivisto UM, Pein Eur Heart J 2015; 36(3): 158-169 ISSN 0195-668X Impact factor: 5.203
Variability of P-wave morphology predicts the outcome of circumferential pulmonary vein isolation in patients with recurrent atrial fibrillation. Huo Y, Holmqvist F, Carlson J, Gaspar T, Hindricks G, Piorkowski C, Bollmann A, Platonov PG J Electrocardiol 2015; 48(2): 218-225 ISSN 0022-0736 Impact factor: 1.361
Outcome of super-responders to cardiac resynchronization therapy defined by endpoint-derived parameters of left ventricular remodeling: a two-center retrospective study. Hurlimann D, Schmidt S, Seifert B, Saguner AM, Hindricks G, Luscher TF, Ruschitzka F, Steffel J Clin Res Cardiol 2015; 104(2): 136-144 ISSN 1861-0684 Impact factor: 4.560
What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets. Iliodromitis EK, Cohen MV, Dagres N, Andreadou I, Kremastinos DT, Downey JM J Cardiovasc Pharmacol Ther 2015; 20(4): 357-369 ISSN 1074-2484 Impact factor: n.n.e.
The role of the heart team in complicated transcatheter aortic valve implantation: a 7-year single-centre experience. Kiefer P, Seeburger J, Noack T, Schroter T, Linke A, Schuler G, Haensig M, Vollroth M, Mohr FW, Holzhey DM Eur J Cardiothorac Surg 2015; 47(6): 1090-1096 ISSN 1010-7940 Impact factor: 3.304
Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study. Kiviniemi T, Airaksinen KE, Rubboli A, Biancari F, Valencia J, Lip GY, Karjalainen PP, Weber M, Laine M, Kirchhof P, Schlitt A Int J Cardiol 2015; 183: 105-110 ISSN 0167-5273 Impact factor: n.n.e.
Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey. Larsen TB, Potpara T, Dagres N, Proclemer A, Sciarrafia E, Blomstrom-Lundqvist C Europace 2015; 17(5): 819-824 ISSN 1099-5129 Impact factor: n.n.e.
Minimally invasive aortic valve replacement: the Leipzig experience. Lehmann S, Merk DR, Etz CD, Seeburger J, Schroeter T, Oberbach A, Uhlemann M, Höllriegel R, Haensig M, Leontyev S, Garbade J, Misfeld M, Mohr FW Ann Cardiothorac Surg 2015; 4(1): 49-56 ISSN 2225-319X Impact factor: 0.000
Minimally invasive aortic valve replacement: the Leipzig experience. Lehmann S, Merk DR, Etz CD, Seeburger J, Schroeter T, Oberbach A, Uhlemann M, Höllriegel R, Haensig M, Leontyev S, Garbade J, Misfeld M, Mohr FW Ann Cardiothorac Surg 2015; 4(1): 49-56 ISSN 2225-319X Impact factor: n.n.e.
Fate of patients with extracorporeal lung assist as a bridge to lung transplantation versus patients without--a single-center experience. Lehmann S, Uhlemann M, Leontyev S, Meyer A, Garbade J, Seeburger J, Laflamme M, Bittner HB, Mohr FW Perfusion 2015; 30(2): 154-160 ISSN 0267-6591 Impact factor: n.n.e.
The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany. Loeffler M, Engel C, Ahnert P, Alfermann D, Arelin K, Baber R, Beutner F, Binder H, Brahler E, Burkhardt R, Ceglarek U, Enzenbach C, Fuchs M, Glaesmer H, Girlich F, Hagendorff A, Hantzsch M, Hegerl U, BMC Public Health 2015; 15: 691 ISSN 1471-2458 Impact factor: 2.264
Serum irisin levels are regulated by acute strenuous exercise. Loffler D, Müller U, Scheuermann K, Friebe D, Gesing J, Bielitz J, Erbs S, Landgraf K, Wagner IV, Kiess W, Korner A J Clin Endocrinol Metab 2015; 100(4): 1289-1299 ISSN 0021-972X Impact factor: 6.209
EHJ's new impact factor of 15.2: a global strategy is paying off. Luscher TF, Bax JJ, Gersh BJ, Hindricks G, Landmesser U, Ruschitzka F, Wijns W Eur Heart J 2015; 36(41): 2763-2766 ISSN 0195-668X Impact factor: n.n.e.
Percutaneous left atrial appendage closure: Technical aspects and prevention of periprocedural complications with the watchman device. Mobius-Winkler S, Majunke N, Sandri M, Mangner N, Linke A, Stone GW, Dähnert I, Schuler G, Sick PB World J Cardiol 2015; 7(2): 65-75 ISSN 1949-8462 Impact factor: 0.000
Initial Experience With a Percutaneous Approach to Redo Mitral Valve Surgery: Management and Procedural Success. Mukherjee C, Holzhey D, Mende M, Linke A, Kaisers UX, Ender J J Cardiothorac Vasc Anesth 2015; 29(4): 889-897 ISSN 1053-0770 Impact factor: 1.463
Proteome profiles of HDL particles of patients with chronic heart failure are associated with immune response and also include bacteria proteins. Oberbach A, Adams V, Schlichting N, Heinrich M, Kullnick Y, Lehmann S, Lehmann S, Feder S, Correia JC, Mohr FW, Volker U, Jehmlich N Clin Chim Acta 2015; 453: 114-122 ISSN 0009-8981 Impact factor: n.n.e.
Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock-a biomarker substudy of the IABP-SHOCK II-Trial. Poss J, Fürnau G, Denks D, Desch S, Eitel I, de Waha S, Linke A, Schuler G, Adams V, Bohm M, Thiele H Eur J Heart Fail 2015; 17(11): 1152-1160 ISSN 1388-9842 Impact factor: n.n.e.
Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA). Potpara TS, Larsen TB, Deharo JC, Rossvoll O, Dagres N, Todd D, Pison L, Proclemer A, Purefellner H, Blomstrom-Lundqvist C Europace 2015; 17(6): 986-993 ISSN 1099-5129 Impact factor: n.n.e.
Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey. Potpara TS, Lenarczyk R, Larsen TB, Deharo JC, Chen J, Dagres N Europace 2015; 17(12): 1862-1867 ISSN 1099-5129 Impact factor: n.n.e.
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM Eur Heart J 2015; 36(41): 2793-2867 ISSN 0195-668X Impact factor: n.n.e.
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM Europace 2015; 17(11): 1601-1687 ISSN 1099-5129 Impact factor: n.n.e.
How are European patients at risk of malignant arrhythmias or sudden cardiac death identified and informed about their risk profile: results of the European Heart Rhythm Association survey. Proclemer A, Bongiorni MG, Dagres N, Sciaraffia E, Todd D, Blomstrom-Lundqvist C Europace 2015; 17(6): 994-998 ISSN 1099-5129 Impact factor: n.n.e.
Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial. Raatikainen MJ, Hakalahti A, Uusimaa P, Nielsen JC, Johannessen A, Hindricks G, Walfridsson H, Pehrson S, Englund A, Hartikainen J, Kongstad O, Mortensen LS, Hansen PS Int J Cardiol 2015; 198: 108-114 ISSN 0167-5273 Impact factor: 4.036
The impact of smoking on long-term outcome of patients with premature (?35years) ST-segment elevation acute myocardial infarction. Rallidis LS, Sakadakis EA, Tympas K, Varounis C, Zolindaki M, Dagres N, Lekakis J Am Heart J 2015; 169(3): 356-362 ISSN 0002-8703 Impact factor: n.n.e.
Circadian pattern of symptoms onset in patients ?35 years presenting with ST-segment elevation acute myocardial infarction. Rallidis LS, Triantafyllis AS, Sakadakis EA, Gialeraki A, Varounis C, Rallidi M, Tsirebolos G, Liakos G, Dagres N, Lekakis J Eur J Intern Med 2015; 26(8): 607-610 ISSN 0953-6205 Impact factor: n.n.e.
Comparison of outcomes of patients with left ventricular ejection fractions ?30% versus ?30% having transcatheter aortic valve implantation (from the German Transcatheter Aortic Valve Interventions Registry). Schaefer U, Zahn R, Abdel-Wahab M, Gerckens U, Linke A, Schneider S, Eggebrecht H, Sievert H, Figulla HR, Senges J, Kuck KH Am J Cardiol 2015; 115(5): 656-663 ISSN 0002-9149 Impact factor: 3.276
Prosthetic Pulmonary Valve Stenosis: A Different Way to Solve the Problem. Schroeter T, Lurz P, Kiefer P, Wehbe M, Dähnert I Ann Thorac Surg 2015; 100: 1103-1105 ISSN 0003-4975 Impact factor: n.n.e.
State of the art of leadless pacing. Sperzel J, Burri H, Gras D, Tjong FV, Knops RE, Hindricks G, Steinwender C, Defaye P Europace 2015; 17(10): 1508-1513 ISSN 1099-5129 Impact factor: n.n.e.
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA, Gulizia M, Halvorsen S, Hindricks G, Kuck KH, Moya A, Potpara T, Roldan V, Tilz R, Lip GY Europace 2015; 17(8): 1197-1214 ISSN 1099-5129 Impact factor: 3.670
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrie D, Naber C, Lipiecki J, Richardt G, Iniguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahar N Engl J Med 2015; 373: 2038-2047 ISSN 0028-4793 Impact factor: n.n.e.
Plasma levels of microRNA in chronic kidney disease: patterns in acute and chronic exercise. Van Craenenbroeck AH, Ledeganck KJ, Van Ackeren K, Jurgens A, Hoymans VY, Fransen E, Adams V, De Winter BY, Verpooten GA, Vrints CJ, Couttenye MM, Van Craenenbroeck EM Am J Physiol Heart Circ Physiol 2015; 309(12): 2008-2016 ISSN 0363-6135 Impact factor: 3.838
Severe right coronary artery injury during minimally invasive tricuspid valve repair. Vollroth M, Sandri M, Garbade J, Mohr FW Eur J Cardiothorac Surg 2015; 48(3): 62 ISSN 1010-7940 Impact factor: n.n.e.
Effective diameter of the aortic annulus prior to transcatheter aortic valve implantation: influence of area-based versus perimeter-based calculation. von Aspern K, Foldyna B, Etz CD, Hoyer A, Girrbach F, Holzhey D, Lucke C, Grothoff M, Linke A, Mohr FW, Gutberlet M, Lehmkuhl L Int J Cardiovasc Imaging 2015; 31(1): 163-169 ISSN 1569-5794 Impact factor: 1.810
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial. Walfridsson H, Walfridsson U, Nielsen JC, Johannessen A, Raatikainen P, Janzon M, Levin LA, Aronsson M, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS Europace 2015; 17(2): 215-221 ISSN 1099-5129 Impact factor: 3.670
Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. Walther T, Hamm CW, Schuler G, Berkowitsch A, Kotting J, Mangner N, Mudra H, Beckmann A, Cremer J, Welz A, Lange R, Kuck KH, Mohr FW, Mollmann H J Am Coll Cardiol 2015; 65(20): 2173-2180 ISSN 0735-1097 Impact factor: 16.503
Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia. Yokokawa M, Kim HM, Baser K, Stevenson W, Nagashima K, Della Bella P, Vergara P, Hindricks G, Arya A, Zeppenfeld K, de Riva Silva M, Daoud EG, Kumar S, Kuck KH, Tilz R, Mathew S, Ghanbari H, Latchamse J Am Coll Cardiol 2015; 65(18): 1954-1959 ISSN 0735-1097 Impact factor: 16.503
Reply: Elimination of All Inducible Ventricular Tachycardias as the Endpoint for Ablation. Yokokawa M, Kim HM, Baser K, Stevenson W, Nagashima K, Della Bella P, Vergara P, Hindricks G, Arya A, Zeppenfeld K, de Riva Silva M, Daoud EG, Kumar S, Kuck KH, Tilz R, Mathew S, Ghanbari H, Latchamse J Am Coll Cardiol 2015; 66(22): 2576-2577 ISSN 0735-1097 Impact factor: n.n.e.
Biolimus-eluting stent with biodegradable polymer improves clinical outcomes in patients with acute myocardial infarction. Zhang YJ, Iqbal J, Windecker S, Linke A, Antoni D, Sohn HY, Corti R, van Es GA, Copt S, Eerdmans P, Saitta R, Morice MC, Di Mario C, Juni P, Wijns W, Buszman P, Serruys PW Heart 2015; 101(4): 271-278 ISSN 1355-6037 Impact factor: 5.595
